JP Morgan Survey: 90% Of Endocrinologists Are Aware Of Crinetics' Atumelnant Data
JP Morgan's survey of endocrinologists finds strong awareness of Crinetics' atumelnant, with positive efficacy impressions.
Here’s why you keep waking up to pee in the middle of the night
Do you ever you wake up once, twice or more during the night to pee? These nighttime wakeups are common but not unsolvable.
Deep Dive Into Neurocrine Biosciences Stock: Analyst Perspectives (14 Ratings)
Return on Assets (ROA): Neurocrine Biosciences's financial strength is reflected in its exceptional ROA, which exceeds ...
HealthDay on MSN18h
Aquablation Appears to Be Safe, Effective for Enlarged Prostates
The Aquablation water-based surgical procedure is safe and effective for use with enlarged prostates compared with laser ...
The Poultry Site23h
IPSF: Chlorine as a treatment for spotty liver disease?
A case report on a spotty liver disease outbreak in two flocks in southern Georgia highlights the limitations of using ...
Tribune Online on MSN18h
The danger in vaginal bleeding
For every woman that has attained puberty, bleeding from the vagina is a natural occurrence at specific periods; this bleeding is ...
BridgeBio Pharma (NASDAQ:BBIO) Given New $50.00 Price Target at JPMorgan Chase & Co.
BridgeBio Pharma (NASDAQ:BBIO – Get Free Report) had its price target increased by equities researchers at JPMorgan Chase & ...
BridgeBio Pharma (NASDAQ:BBIO) Trading 8.9% Higher Following Analyst Upgrade
Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) shot up 8.9% during trading on Monday after JPMorgan Chase & Co. raised their price target on the stock from $44.00 to $50.00. JPMorgan ...